The role of cerebral serotonin in the development of tolerance to centrally administered phenobarbital.
Chronic intracerebroventricular injection of phenobarbital results in the development of tolerance to the depressant effects of the drug. The neurotransmitters involved and the manner in which cerebral neurons adapt to this depressant effect are at present unknown. This study examines whether brain serotonin containing neurons participate in the attenuation of the hypnotic response caused by chronic barbiturate administration. Depletion of serotonin with p-chlorophenylalanine, p-chloroamphetamine and 5,7-dihydroxytryptamine did not affect the initial dose-response curve to the centrally injected barbiturate, but all treatments resulted in significant delays in tolerance development. A negative correlation between the extent of whole brain serotonin remaining and the duration of loss of righting reflex on the last day of the chronic phenobarbital regimen was obtained after pretreatment with p-chlorophenylalanine, p-chloroamphetamine and saline. The sleep times of animals pretreated with 5,7-dihydroxytryptamine did not fit this linear relationship. Treatment with p-chloroamphetamine after cessation of the chronic phenobarbital regimen did not influence the rate of tolerance reversal. Steady state levels of serotonin and the concentration of its metabolite, 5-hydroxyindoleacetic acid, in different brain areas were comparable in controls and tolerant rats when examined at various stages intolerance development. However, tolerant and non-tolerant rats sacrificed at time points immmediately after central phenobarbital injection had different temporal patterns of 5-hydroxyindoleacetic acid elevation in the striatum, hypothalamus and midbrain which were observable only during the loss of righting reflex. The data indicate that cerebral serotonin neurons participate in the attenuation of hypnosis following chronic phenobarbital injections.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D004102:Dihydroxytryptamines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D010134:Fenclonine / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D010634:Phenobarbital / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000502:physiology*; D010133:p-Chloroamphetamine / Q000494:pharmacology
D004102:Dihydroxytryptamines; D012701:Serotonin; D010133:p-Chloroamphetamine; D010134:Fenclonine; D010634:Phenobarbital